ConductScience.org, home

Paper33520751

Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.

Ramstad E and 13 others. Scand J Child Adolesc Psychiatr Psychol, 2018. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. Papers, record 33520751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33520751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.
PubMed
Journal
Scand J Child Adolesc Psychiatr Psychol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.18
iCite
Revised in PubMed
2023-11-10
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ramstad EErica
2Storebø OJOle Jakob
3Gerner TTrine
4Krogh HBHelle B
5Holmskov MMathilde
6Magnusson FLFrederik L
7Moreira-Maia CRCarlos R
8Skoog MMaria
9Groth CCamilla
10Gillies DDonna
11Zwi MMorris
12Kirubakaran RRichard
13Gluud CChristian
14Simonsen EErik

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125885010Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.J Child Adolesc Psychopharmacol2015https://conductscience.org/library/papers/25885010PubMed
221871372Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.J Am Acad Child Adolesc Psychiatry2011https://conductscience.org/library/papers/21871372PubMed
326719291Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness.Pediatrics2016https://conductscience.org/library/papers/26719291PubMed
425416419Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods.BMC Med Res Methodol2014https://conductscience.org/library/papers/25416419PubMed
517581453Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry2007https://conductscience.org/library/papers/17581453PubMed
619587853Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.Curr Neuropharmacol2008https://conductscience.org/library/papers/19587853PubMed
726267421Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder.J Clin Psychopharmacol2015https://conductscience.org/library/papers/26267421PubMed
823312392GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.J Clin Epidemiol2013https://conductscience.org/library/papers/23312392PubMed
929744873Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29744873PubMed
1010585981A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.Pediatrics1999https://conductscience.org/library/papers/10585981PubMed
1119622552The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ2009https://conductscience.org/library/papers/19622552PubMed
1218942172Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.Ann Intern Med2008https://conductscience.org/library/papers/18942172PubMed
1319621072Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med2009https://conductscience.org/library/papers/19621072PubMed
1418294084Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder.J Child Adolesc Psychopharmacol2008https://conductscience.org/library/papers/18294084PubMed
1519502578Methylphenidate induction of complex visual hallucinations.J Child Neurol2009https://conductscience.org/library/papers/19502578PubMed
1618083463Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.J Clin Epidemiol2008https://conductscience.org/library/papers/18083463PubMed
1721497704Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.Clin Ther2011https://conductscience.org/library/papers/21497704PubMed
1826363968Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.Schizophr Res2015https://conductscience.org/library/papers/26363968PubMed
1917541055The worldwide prevalence of ADHD: a systematic review and metaregression analysis.Am J Psychiatry2007https://conductscience.org/library/papers/17541055PubMed
2026608309Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.BMJ2015https://conductscience.org/library/papers/26608309PubMed

See all 78 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42847833Investigating Potential Adverse Drug Reactions of Lisdexamfetamine Using Sequence Symmetry Analysis.Basic Clin Pharmacol Toxicol2026https://conductscience.org/library/papers/42847833PubMed
42656627
Disproportionality analysis of methylphenidate-associated adverse events in pediatric patients using the FDA Adverse Event Reporting System: overall signals and stratification by gender and dosage form.
Front Psychiatry2026https://conductscience.org/library/papers/42656627PubMed
41916954Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study.Transl Psychiatry2026https://conductscience.org/library/papers/41916954PubMed
41879751Methylphenidate Treatment and Risk of Psychotic Disorder.JAMA Psychiatry2026https://conductscience.org/library/papers/41879751PubMed
40422911Gut-Brain Inflammatory Pathways in Attention-Deficit/Hyperactivity Disorder: The Role and Therapeutic Potential of Diet.Metabolites2025https://conductscience.org/library/papers/40422911PubMed
39583637Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet® MR and Concerta®) - a Danish nationwide register-based cohort study.Scand J Child Adolesc Psychiatr Psychol2024https://conductscience.org/library/papers/39583637PubMed
38609318Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults.BMJ Ment Health2024https://conductscience.org/library/papers/38609318PubMed
37585250The Adverse Effects and Nonmedical Use of Methylphenidate Before and After the Outbreak of COVID-19: Machine Learning Analysis.J Med Internet Res2023https://conductscience.org/library/papers/37585250PubMed
36860219Psychosis Induced by Methylphenidate in Children and Young Patients With Attention-Deficit Hyperactivity Disorder.Cureus2023https://conductscience.org/library/papers/36860219PubMed
34449694Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?Pediatr Rep2021https://conductscience.org/library/papers/34449694PubMed
33520746Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research.Scand J Child Adolesc Psychiatr Psychol2018https://conductscience.org/library/papers/33520746PubMed
31221557Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study.Lancet Psychiatry2019https://conductscience.org/library/papers/31221557PubMed
29744873Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29744873PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SNAP256616PubTator's text mininghttps://conductscience.org/library/genes/6616

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33520751

GET https://conductscience.org/api/papers/v1/33520751/references?page=2